Furthermore, post-hoc comparisons confirmed that compound G, with (298,416 ± 73,236; p = 0.0085) or without rhBDNF (p = 0.0002), significantly dampened stroke-induced elevations in GFAP+ve expression in the PI, relative to vehicle-treated controls. Here, GFAP is linked to stroke disorder.